Sharon Tzelnick
Overview
Explore the profile of Sharon Tzelnick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tzelnick S, de Almeida J, Gilbert R, Goldstein D
OTO Open
. 2024 Aug;
8(3):e179.
PMID: 39157740
Objective: Treatment options for recurrent early glottic carcinoma's include conservative and radical surgical options. These options offer similar survival benefits with different impacts of patient's quality of life. We previously...
2.
Tzelnick S, Tsai J, Hosni A, Goldstein D, de Almeida J, Yao C
J Otolaryngol Head Neck Surg
. 2024 Jul;
53:19160216241265092.
PMID: 39077912
Importance: A gap in knowledge exists concerning the functional outcomes and complications when comparing various surgical approaches for retropharyngeal lymph node (RPLN) metastases. Objective: To explore perioperative outcomes, functional outcomes,...
3.
Sarkis L, Yao C, Hendler A, Mohan R, Au M, Zhang H, et al.
Head Neck
. 2024 Jul;
46(12):3038-3045.
PMID: 39016220
Background: Lymphatic mapping with SPECT-CT has been demonstrated to accurately define lymphatic drainage patterns in oropharyngeal cancer but there has yet to be a study demonstrating its feasibility across multiple...
4.
Tzelnick S, de Almeida J, Yao C, Kibel S, Kuehne N, Grewal R, et al.
Laryngoscope
. 2024 Jun;
134(10):4292-4297.
PMID: 38828642
Objective: Stage 3 patients with clinically positive nodal metastasis are treated with therapeutic neck dissection and adjuvant systemic therapy. The aim of our study was to examined the predictability of...
5.
Vainer I, Tzelnick S, Kurman N, Popovtzer A, Soudry E
Clin Otolaryngol
. 2024 Apr;
49(4):506-511.
PMID: 38572684
Objective: The purpose of this study was to investigate whether patient, tumour and radiation therapy factors are associated with development of middle ear effusion (MEE) in nasopharyngeal carcinoma (NPC) patients....
6.
Cohen O, Tzelnick S, Randolph G, Rinaldo A, Alvarez F, Rodrigo J, et al.
Clin Endocrinol (Oxf)
. 2024 Mar;
100(5):468-476.
PMID: 38472743
Introduction: Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor from parafollicular cells that produce calcitonin (Ct). Despite several existing guidelines for the surgical management of sporadic MTC (sMTC), optimal...
7.
Sahovaler A, Valic M, Townson J, Chan H, Zheng M, Tzelnick S, et al.
Cancer Res Commun
. 2024 Feb;
4(3):796-810.
PMID: 38421899
Significance: PS-PDT is a safe and repeatable treatment modality for OCSCC ablation. PS demonstrated tumor selective uptake and PS-PDT treatments achieved reproducible efficacy and effectiveness in multiple tumor models superior...
8.
Yosefof E, Tsur N, Zavdy O, Kurman N, Dudkiewicz D, Yehuda M, et al.
Laryngoscope
. 2023 Nov;
134(5):2212-2220.
PMID: 37965942
Background: Regional metastases are considered the most important prognostic factor in OSCC patients. We aimed to investigate the impact of regional disease among different age groups with OSCC. Methods: A...
9.
Tsur N, Segal E, Kurman N, Tzelnick S, Wiesel O, Wilk L, et al.
BJR Open
. 2023 Nov;
5(1):20230001.
PMID: 37942493
Objective: To evaluate patient characteristics, risk factors, disease course, and management of cervical vertebral osteomyelitis in patients who had radiation for head and neck cancers. Methods: A retrospective cohort study...
10.
Tzelnick S, Peretz Soroka H, Tasnim N, Gilbert R, Irish J, Goldstein D, et al.
Oral Oncol
. 2023 Jul;
145:106495.
PMID: 37478572
Objective: The aim of the study is to describe the factors that influence outcome in adults with head and neck osteosarcoma (HNO) with a specific focus on the margin status....